3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
41
INDUSTRY
32
NIH
21
NETWORK
20
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Esophageal Neoplasms
7
Breast Neoplasms
6
Stomach Neoplasms
4
Uterine Cervical Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thymoma
1
Small Cell Lung Carcinoma
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Carcinoma, Ovarian Epithelial
1
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
1
Interventions
Hyperthermic Intraperitoneal Chemotherapy
2
pembrolizumab
1
lenvatinib
1
fluzoparib
1
apatinib
1
Surgical Procedures, Operative
1
Quality of Life
1
Paclitaxel
1
Nutritional Status
1
Neoadjuvant Therapy
1
Interviews as Topic
1
Indocyanine Green
1
Drug Therapy
1
Diagnostic Imaging
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Carcinoma, Ovarian Epithelial
×
Paclitaxel
×
Clear all
NCT01654146
2012-07-31
ICON8
Medical Research Council
Phase 3
Unknown
1,485 enrolled